Skip to Main Content

COVID - 19 Research Resources: Databases

Announcement

During this unprecedented pandemic, many publishers have offered access to their resources for free. SU Libraries has added these under Trial Databases section. Please note these are available temporarily and their end date varies.

Available through SU Libraries

Available on the Web (some free)

  • LitCovid - LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus. It is the most comprehensive  resource on the subject, providing a central access to 2297 (and growing) relevant articles in PubMed.
     
  • Coronavirus (COVID-19): evidence relevant to critical care from the Cochrane Library
     
  • Elsevier's Health and Medical Research - Elsevier’s free health and medical research on the novel coronavirus (SARS-CoV-2) and COVID-19. Includes Clinical Information, Research/Drug Discovery
     
  • TRIP Database - Starting in 1997, TRIP is a clinical search engine  to quickly and easily find and use high-quality research evidence to support their practice and/or care. Based on user searches recently, they have curated medical articles on Covid-19; Covid-19 guidelines; Covid-19 and pregnancy; Covid- 19 and chloroquine; Covid-19 and diagnosis; Covid-19 AND PPE
     
  • ECRI COVID-19 Resource Center - Emergency Care Research Institute (ECRI)  has developed this resource center to help hospitals, ambulatory care, and aging care facilities protect healthcare workers, residents, and patients
     
  • COVID-19 JAMA Network -  The Journal of the Medical Association (JAMA) has created an entire section on COVID -19 information which includes a live interactive map, Q & A with Dr. Anthony Fauci, past publications on vaccine development, infection control, and public health preparedness.
     
  • Coronavirus: Research, Commentary and News - from The American Association of Advancement of Science (AAAS). "The Science journals are striving to provide the best and most timely research, analysis, and news coverage of COVID-19 and the coronavirus that causes it. All content is free to access."